These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6368332)

  • 1. Metergoline in the management of normoprolactinemic secondary amenorrhea. A multicentric controlled trial.
    Fadini R; Meschia M; Crosignani PG; Falsetti L; Vignali M; Ferla P; Cavagnini F; Pinto M; Travaglini P; Faglia
    Gynecol Obstet Invest; 1984; 17(1):47-53. PubMed ID: 6368332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metergoline in the management of hyperprolactinemic amenorrhea and anovulation.
    Falsetti L; Voltolini AM; Crosignani PG; Lotti G; Travaglini P; Faglia G; Cianci A; Palumbo G; Praga C; Pontiroli AE
    Gynecol Obstet Invest; 1982; 13(2):108-16. PubMed ID: 7035305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metergoline and bromocriptine in the management of tumoral and idiopathic hyperprolactinemia.
    Falsetti L; Roggia A; Loda G; Turla R; Scagliola T; Schimberni M; Pontiroli AE
    Horm Metab Res; 1983 Aug; 15(8):380-4. PubMed ID: 6618428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of cyclic ovarian function by metergoline treatment in a patient with a prolactin-secreting pituitary microadenoma.
    Ferrari C; Caldara R; Telloli P; Rampini P; Bertazzoni A
    Fertil Steril; 1978 Aug; 30(2):237-9. PubMed ID: 680200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiserotonin treatment of hyperprolactinemic amenorrhea: long-term follow-up with metergoline, methysergide, and cyproheptadine.
    Crosignani PG; Peracchi M; Lombroso GC; Reschini E; Mattei A; Caccamo A; D'Alberton A
    Am J Obstet Gynecol; 1978 Oct; 132(3):307-12. PubMed ID: 707571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experiences with the prolactin-inhibiting serotonin antagonist metergoline].
    Schneider WH; Huber H; Spona J
    Wien Klin Wochenschr; 1983 Jun; 95(13):452-5. PubMed ID: 6636776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metergoline as an alternative to bromocriptine in amenorrhoea.
    Hicks BH; Finer N; Herbert LC
    Acta Endocrinol (Copenh); 1984 Dec; 107(4):439-44. PubMed ID: 6440388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
    Farrari C; Telloli P; Rampini P; Caldara R
    Gynecol Obstet Invest; 1980; 11(6):317-26. PubMed ID: 6785158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hyperprolactinemic amenorrhea with Metergoline.
    Bohnet HG; Kato K; Wolf AS
    Obstet Gynecol; 1986 Feb; 67(2):249-52. PubMed ID: 3945435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of the prolactin response to sulpiride by metergoline administration in hyperprolactinemic patients.
    Ferrari C; Travaglini P; Caldara R; Moriondo P; Mattei A; Crosignani PG; Faglia G
    Neuroendocrinology; 1979; 29(5):338-45. PubMed ID: 503288
    [No Abstract]   [Full Text] [Related]  

  • 11. [Methergoline therapy of hyperprolactinemic amenorrhea. Observations on 22 cases].
    Rossetti MG; Belforte L; Bruno M; Lanza MG; Peris C; Vaudano G; Campagnoli C
    Minerva Ginecol; 1981 Jun; 33(6):586-9. PubMed ID: 7279283
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum prolactin and ovarian function after discontinuation of drug treatment for hyperprolactinaemia: a study with bromocriptine and metergoline.
    Mattei AM; Ferrari C; Ragni G; Benco R; Picciotti MC; Rampini P; Caldara R; Crosignani PG
    Br J Obstet Gynaecol; 1984 Mar; 91(3):244-50. PubMed ID: 6704349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metergoline treatment of hyperprolactinemic states.
    Crosignani PG; Ferrari C; Mattei A; Fadini R; Meschia M; Caldara R; Rampini P; Telloli P; Reschini E
    Fertil Steril; 1979 Sep; 32(3):280-5. PubMed ID: 488408
    [No Abstract]   [Full Text] [Related]  

  • 14. Pregnancy following metergoline treatment in a patient with hyperprolactinaemia.
    Crosignani PG; Reschini E; Peracchi M; D'Alberton A; Lombroso GC
    Br J Obstet Gynaecol; 1977 May; 84(5):386-8. PubMed ID: 889732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine profile and therapeutic employment of a new prolactin-lowering drug, metergoline.
    Ferrari C; Reschini E; Peracchi M; Crosignani PG
    Gynecol Obstet Invest; 1980; 11(1):1-16. PubMed ID: 6248438
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma concentrations of prolactin in overtly pseudopregnant Afghan hounds and the effect of metergoline.
    Okkens AC; Dieleman SJ; Kooistra HS; Bevers MM
    J Reprod Fertil Suppl; 1997; 51():295-301. PubMed ID: 9404298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma prolactin concentration and the effect of metergoline in pseudopregnant Afghan hounds].
    Okkens AC; Dieleman SJ; Kooistra HS; Bevers MM
    Tijdschr Diergeneeskd; 2000 Feb; 125(3):81-5. PubMed ID: 10680206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term treatment with metergoline in patients with idiopathic oligospermia.
    Masala A; Delitala G; Alagna S; Devilla L; Rovasio PP
    Clin Endocrinol (Oxf); 1979 Sep; 11(3):349-52. PubMed ID: 509746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metergoline as an inhibitor of prolactin release.
    Caballero A; Mena P; Caballero-Díaz JL; Caballero-Asensi A
    J Reprod Med; 1987 Feb; 32(2):115-9. PubMed ID: 3560070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methergoline in the treatment of prolactinemia in women].
    Radowicki S
    Ginekol Pol; 1983; 54(11-12):729-35. PubMed ID: 6368327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.